Dec 8, 2020

Special nursing program focused on PARP inhibitors. This program includes case discussions from the practices of Deborah Wright, MSN, APRN, CNS, Jamie Carroll, APRN, MSN, CNP, Tammy Triglianos, RN, MS, ANP-BC, AOCNP and Erika Meneely, APRN, BC. Access NCPD information and select publications here.

• Case: A woman in her late 40s with ovarian cancer — Deborah Wright, MSN, APRN, CNS
• Case: A woman in her early 50s with Stage IIIB high-grade serous ovarian cancer — Ms Wright
• Case: A woman in her mid-50s with Stage IIIC high-grade serous ovarian cancer — Ms Wright
• Case: A woman in her early 40s with metastatic triple-negative breast cancer (TNBC) and a germline BRCA mutation — Jamie Carroll, APRN, MSN, CNP
• Case: A woman in her early 50s with ER-positive, HER2-negative breast cancer and a BRCA germline mutation — Ms Carroll
• Case: A woman in her late 50s with metastatic TNBC and a germline BRCA mutation — Ms Carroll
• Case: A man in his late 60s with metastatic pancreatic cancer — Tammy Triglianos, RN, MS, ANP-BC, AOCNP
• Case: A man in his late 60s with metastatic pancreatic cancer — Ms Triglianos
• Case: A man in his early 50s with metastatic prostate cancer — Erika Meneely, APRN, BC
• Case: A man in his early 60s with metastatic prostate cancer — Ms Meneely
• Case: A man in his early 70s with metastatic prostate cancer — Ms Meneel